149P Clinical outcomes in ER+ breast cancer patients with recurrence score 26-30-guided therapy: Real-world data

Autor: O. Rotem, I. Peretz, M. Leviov, I. Kuchuk, A. Itay, M. Tokar, S. Paluch-Shimon, O. Maimon, R. Yerushalmi, K. Drumea, E. Evron, A. Sonnenblick, E. Nili Gal Yam, H. Goldvaser, S.G. Yosef, R. Merose, A. Bareket-Samish, L. Soussan-Gutman, S. Stemmer

Publikováno v: Annals of Oncology. 33:S607-S608

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ea4c19e8687531331e07b28e70b61f62
https://doi.org/10.1016/j.annonc.2022.07.184

Whole population BRCA screening is cost effective in Israel, even with varying prevalence of BRCA mutation

Autor: Nadav Michaan, R. Merose, M. Lashno, Dan Grisaru, Tamar Safra, Ido Laskov

Publikováno v: Gynecologic Oncology. 154:224-225

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::17e985c28d6c699f9c32e0575f6a6ef9
https://doi.org/10.1016/j.ygyno.2019.04.520

ER + HER2- early-stage breast cancer: association of HER2 expression, tumor characteristics, and outcomes.

Autor: Goldvaser H; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1101 Hempstead Turnpike, Uniondale, NY, 11553, USA. hadar7g@gmail.com., Yerushalmi R; Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel.; Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel., Mutai R; Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel.; Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel., Kuchuk I; Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.; The Oncology Institute, Meir Medical Center, Tel-Aviv University, Kfar Saba, Israel., Toker M; Soroka University Medical Center, Beer Sheva, Israel.; Faculty of Medicine, Ben Gurion University, Beer Sheva, Israel., Paluch-Shimon S; Hadassah University Hospital, Jerusalem, Israel.; Faculty of Medicine, the Hebrew University, Jerusalem, Israel Jerusalem, Israel., Drumea K; Lin Medical Center, Haifa, Israel.; Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel., Evron E; Faculty of Medicine, the Hebrew University, Jerusalem, Israel Jerusalem, Israel.; Kaplan Medical Center, Rehovot, Israel., Sonnenblick A; Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.; Sourasky Medical Center, Tel Aviv, Israel., Gal-Yam E; Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.; Sheba Medical Center, Ramat Gan, Israel., Sela GB; Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.; Emek Medical Center, Afula, Israel., Shai A; Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.; Rambam Health Care Campus, Haifa, Israel., Merose R; Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.; Shamir Medical Center, Rishon LeZion, Israel., Bareket-Samish A; BioInsight Ltd, Binyamina, Israel., Soussan-Gutman L; Oncotest-Rhenium, Modi'in, Israel., Stemmer SM; Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel.; Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Nov 19. Date of Electronic Publication: 2024 Nov 19.

[GERIATRIC ONCOLOGY - CANCER TREATMENT IN OLDER ADULTS AND OLDEST-OLD].

Autor: Leibowitz R; Oncology Institute, Shamir Medical Center, Zerifin, Be'er Ya'akov, Israel.; Department of Oncology, Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Plotnikov G; Geriatric Assessment Unit, Shamir Medical Center, Zerifin, Be'er Ya'akov, Israel., Yarom N; Oncology Institute, Shamir Medical Center, Zerifin, Be'er Ya'akov, Israel., Merose R; Oncology Institute, Shamir Medical Center, Zerifin, Be'er Ya'akov, Israel.

Publikováno v: Harefuah [Harefuah] 2022 Jan; Vol. 161 (1), pp. 21-25.